Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Helios University Hospital Wuppertal
Novartis
SWOG Cancer Research Network
H. Lee Moffitt Cancer Center and Research Institute
Dana-Farber Cancer Institute
Providence Health & Services
Pfizer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
SWOG Cancer Research Network
City of Hope Medical Center
Thomas Jefferson University
National Cancer Institute (NCI)
Spanish Breast Cancer Research Group
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Regina Elena Cancer Institute
NantBioScience, Inc.
National Cancer Institute (NCI)
University Medical Center Groningen
Organon and Co
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Canadian Cancer Trials Group
University of Nebraska
Canadian Cancer Trials Group
Georgetown University
Rutgers, The State University of New Jersey
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Wake Forest University Health Sciences
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Barbara Ann Karmanos Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Vanderbilt University
Rutgers, The State University of New Jersey
Alliance for Clinical Trials in Oncology
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Memorial Sloan Kettering Cancer Center
University of Leeds
NRG Oncology
H. Lee Moffitt Cancer Center and Research Institute
NSABP Foundation Inc
University of South Florida
National Cancer Institute (NCI)
University of Southampton
H. Lee Moffitt Cancer Center and Research Institute